BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Cardiol Therapeutics Announces Year-End 2025 Update on Operations

  April 1, 2026

   · 

  14 min read
• Press Releases

  Dr. Christina Rahm Named One of MSN’s “Top 10 Trailblazing Women in 2026"

  April 1, 2026

   · 

  2 min read
• Press Releases

  Resverlogix Corp. Provides Bi-Weekly MCTO Status Update

  April 1, 2026

   · 

  4 min read
• 

  Business

  11 Startups Selected for National Life Sciences Accelerator Program

  Of the 11 companies participating in the spring cohorts of the Drive program run by MassBio and SCbio, eight have locations in Massachusetts. One cohort focuses on biotech and the other on biomarkers and diagnostics.

  April 1, 2026

   · 

  2 min read

   · 

  Angela Gabriel
• 

  Approvals

  Eli Lilly’s Oral Obesity Pill Approved, Kicking Off Renewed Novo Rivalry

  The FDA approved Eli Lilly’s orforglipron—to be known as Foundayo—on Wednesday, officially igniting what analysts believe will be a fierce rivalry with Novo Nordisk’s oral Wegovy.

  April 1, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Layoffs

  Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment

  As Novo Nordisk cuts 400 jobs at the troubled site, Scholar Rock has seen enough progress that it included the facility in a resubmission for FDA approval.

  April 1, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  PreveCeutical Adopts Semi-Annual Financial Reporting

  April 1, 2026

   · 

  2 min read